Ranbaxy Laboratories (Delisted) share price
BSE: 500359
Ranbaxy Laboratories Ltd. · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last traded ₹859.80 on 1 Apr 2015
Delisted on 30 Mar 2016.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Mar 2015
25 Mar · Suspension of trading in equity shares
Members of the Exchange are hereby informed that the trading in equity shares of Ranbaxy Laboratories Limited shall be suspended w.e.f. April 06, 2015 (i.e. closing hours of trading on April 1, 2015) on account of Scheme of Amalgamation with Sun Pharmaceuticals Industries Limited.25 Mar · Corporate action
Company has fixed Record Date as April 7, 2015 to determine the names of the shareholders of erstwhile Ranbaxy who would be entitled to receive 8 ( eight) equity shares of Re.1 each of the Company for every 10 (ten) equity shares of Rs.5 each of erstwhile Ranbaxy held and to determine the names of the NCD holders who would be entitled to 1 (One) NCD of Rs.1 lac each of the Company for every 1 (One) NCD of Rs.1 lac each held in erstwhile Ranbaxy pursuant to amalgamation of erstwhile Ranbaxy into the Company.
Results for the quarter to Dec 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹1,010 Cr−26.1% on a year ago · −23.4% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹1,420 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −140.7%
From revenue to net profit, ₹ crore
- Revenue1,010
- Other income+18
- One-off items−27
- Finance costs−149
- Profit before tax−565
- Tax−855
- Net profit−1,420
Ranbaxy Laboratories results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2014. Results for the quarter to Mar 2015 were due by 15 May 2015, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹2,179 Cr, quarter to Jun 2014; lowest ₹1,010 Cr, quarter to Dec 2014A loss in 7 of the 12 quarters shown
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 2,266 | 1,123 | 1,181 | – | 1,096 | 1,282 | 1,425 | 3,888 | 1,921 | 1,526 | 1,470 | 1,442 | 1,382 | 1,439 | 1,426 | 1,367 | 1,252 | 2,179 | 1,319 | 1,010 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 532 | 114 | 115 | – | 43 | 80 | 169 | 209 | 602 | 578 | 554 | 590 | 560 | 579 | 541 | 569 | 623 | 568 | 664 | 589 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 150 | 111 | 177 | – | 81 | 45 | 104 | 120 | 130 | 61 | 58 | 67 | 52 | 31 | 44 | 21 | 637 | 26 | 20 | 18 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 22 | 124 | 10 | – | 35 | 15 | 14 | 270 | 17 | 163 | −17 | 134 | 51 | 156 | 111 | 118 | 111 | 142 | 137 | 149 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | 1,264 | 17 | 146 | – | −55 | 52 | 221 | 776 | 483 | −326 | 262 | −201 | −12 | −321 | −263 | −210 | 438 | 745 | −333 | −538 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | −16 | 98 | – | 2 | 93 | −651 | −3,486 | 345 | −599 | 290 | −417 | 82 | −288 | −579 | −186 | 490 | 20 | −36 | −27 |
| Profit before tax | 1,264 | 1 | 244 | – | −53 | 145 | −430 | −2,710 | 827 | −926 | 552 | −618 | 70 | −609 | −842 | −396 | 928 | 764 | −368 | −565 |
| Tax | 392 | 1 | 22 | – | 0 | −5 | 9 | – | – | – | – | −2 | – | – | – | – | 31 | 9 | – | 855 |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | 31.0% | 106.9% | 9.1% | – | – | −3.8% | – | – | – | – | – | – | – | – | – | – | 3.3% | 1.2% | – | – |
| Net profit | 872 | 0 | 222 | – | −53 | 150 | −439 | −2,710 | 827 | −926 | 552 | −616 | 70 | −609 | −842 | −396 | 898 | 755 | −368 | −1,420 |
| Net margin | 38.5% | 0.0% | 18.8% | – | −4.8% | 11.7% | −30.8% | −69.7% | 43.1% | −60.7% | 37.6% | −42.7% | 5.1% | −42.3% | −59.1% | −29.0% | 71.7% | 34.7% | −27.9% | −140.7% |
| Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary | ₹20.73 | – | ₹5.27 | – | −₹1.26 | ₹3.57 | −₹10.42 | −₹64.28 | ₹19.62 | −₹21.95 | ₹13.09 | −₹14.59 | ₹1.66 | −₹14.40 | −₹19.92 | −₹9.36 | ₹21.22 | ₹17.83 | – | – |
| Diluted earnings per shareDiluted earnings per share. Earnings per share counting the shares that options, warrants and convertible bonds already granted would add, on today's share count after splits and bonuses. Diluted earnings per share in the glossary | ₹17.78 | – | ₹3.67 | – | −₹1.26 | ₹3.57 | −₹10.42 | −₹64.28 | ₹19.58 | −₹21.95 | ₹13.05 | −₹14.59 | ₹1.66 | −₹14.40 | −₹19.92 | −₹9.36 | ₹21.19 | ₹17.80 | – | – |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Dec 2010.
6 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to December.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
A loss in 3 of the 6 years shown
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net margin
The years either side of a change of basis do not compare. From the year to Dec 2008, the company's revenue for that year, ₹4,472 Cr, differs from its quarters added, ₹4,350 Cr.
Results for the year to Dec 2012
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue6,304
- Other income+240
- One-off items−381
- Finance costs−297
- Profit before tax−164
- Tax+1.9
- Net profit−162
Profit and loss
Standalone, ₹ crore, years to December. The last column is the twelve months to Dec 2014, the latest four quarters added.
| ₹ crore | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2014Twelve months |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 4,034 | 4,472 | 4,783 | 5,672 | 7,690 | 6,304 | 5,759 |
| – | – | – | – | – | – | – | |
| Materials and goods bought | 1,526 | 421 | 446 | 491 | 501 | 2,288 | 2,444 |
| Other income | 341 | 210 | 276 | 360 | 346 | 240 | 700 |
| Finance costs | 92 | 893 | −110 | 54 | 604 | 297 | 539 |
| Profit before one-off items and tax | – | −1,619 | 1,062 | 1,311 | 724 | 217 | 312 |
| One-off items | 36 | – | – | 255 | −3,772 | −381 | 447 |
| Profit before tax | 782 | −1,619 | 1,062 | 1,565 | −3,049 | −164 | 759 |
| Tax | 159 | −574 | 490 | 417 | 3 | −2 | – |
| Net profit | 623 | −1,045 | 572 | 1,149 | −3,052 | −162 | −136 |
| Net margin | 15.4% | −23.4% | 12.0% | 20.3% | −39.7% | −2.6% | −2.4% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Dec 2007, Dec 2008, Dec 2009, Dec 2010, Dec 2011 and Dec 2012: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to December.
| Ratio | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 |
|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | 6.9% | 18.6% | 35.6% | −18.0% |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. Net profit growth in the glossary | – | 100.8% | – | – |
| Earnings per share growthEarnings per share growth. This year's earnings per share less last year's, on the same share count, divided by last year's, times 100; blank where last year's is not above nought. Earnings per share growth in the glossary | – | 100.6% | – | – |
Revenue growth is left blank for the year to Dec 2008: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Dec 2012.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | – | 9.6% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −6.7% | −7.3% |
Accounting checks
Standalone, years to December. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 |
|---|---|---|---|---|
| Effective tax ratePublished threshold 17.16 per cent | 46.14 | 26.61 | – | – |
A threshold marked as ours has no published figure; it is the line we read the check against.
Where the return came from
Yearly rates to Dec 2012, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +24.2% | – | – | 0.0% |
| 3 years | −0.9% | – | – | 0.0% |
| 5 years | +3.4% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Ranbaxy Laboratories share price by year
Each calendar year to 2015.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2015 | 859.80 | +36.9% | 859.80 | 611.70 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 1 Apr 2015.
Recent sessions
The 10 trading days to 1 Apr 2015, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 1 Apr 2015 | 814.70 | 869.70 | 809.45 | 859.80 | 846.55 | 54,15,702 |
| 31 Mar 2015 | 809.00 | 824.45 | 801.95 | 814.00 | 814.25 | 8,87,942 |
| 30 Mar 2015 | 810.10 | 816.20 | 790.10 | 806.65 | 807.33 | 5,91,267 |
| 27 Mar 2015 | 827.50 | 829.50 | 798.50 | 805.20 | 808.51 | 7,82,388 |
| 26 Mar 2015 | 834.00 | 834.30 | 812.20 | 819.30 | 823.22 | 31,57,649 |
| 25 Mar 2015 | 832.00 | 839.00 | 820.25 | 831.20 | 829.87 | 24,54,865 |
| 24 Mar 2015 | 811.90 | 827.60 | 810.00 | 819.05 | 818.57 | 18,76,044 |
| 23 Mar 2015 | 814.80 | 821.50 | 796.60 | 804.60 | 808.69 | 6,78,300 |
| 20 Mar 2015 | 828.00 | 843.85 | 803.15 | 808.90 | 819.48 | 12,37,650 |
| 19 Mar 2015 | 825.70 | 845.35 | 814.50 | 824.15 | 835.44 | 15,44,895 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 16 Sep 2013 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for. |
| 8 Aug 2013 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company's board met on results that day or since the trading day before. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- BSE code
- 500359
- ISIN
- INE015A01028
- Former symbols
- RANBAXY
- Website
- www.ranbaxy.com
- CIN
- L24231PB1961PLC003747
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1961
- Registered office
- A-41, Industrial Area Phase VIII-A, Sahibzada Ajit Singh Nagar, Mohali 160071, Punjab
- Share registrar
- Alankit Assignments Ltd
- Keeps the register of shareholders and handles transfers and dividend payments